Guz K - Search Results

1

Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations.

Clausen FB, Hellberg Å, Bein G, Bugert P, Schwartz D, Drnovsek TD, Finning K, Guz K, Haimila K, Henny C, O'Brien H, Orzinska A, Sørensen K, Thorlacius S, Wikman A, Denomme GA, Flegel WA, Gassner C, de Haas M, Hyland C, Ji Y, Lane WJ, Nogués N, Olsson ML, Peyrard T, van der Schoot CE, Weinstock C, Legler T. Clausen FB, et al. Among authors: guz k. Vox Sang. 2022 Feb;117(2):157-165. doi: 10.1111/vox.13172. Epub 2021 Jun 21. Vox Sang. 2022. PMID: 34155647 Free PMC article. Review.

2

[Non-invasive fetal RhD typing and RhD negative pregnant women--preliminary observations].

Guz K, Brojer E, Zupańska B, Orzińska A, Kalińska A, Bec JR. Guz K, et al. Ginekol Pol. 2004 Jan;75(1):21-5. Ginekol Pol. 2004. PMID: 15112469 Polish.

3

[Examination of the RHD gene by non-invasive method in plasma of alloimmunized mother allowed to abandon invasive procedures and to deliver a healthy child].

Orzińska A, Guz K, Brojer E, Zupańska B. Orzińska A, et al. Among authors: guz k. Ginekol Pol. 2004 Dec;75(12):963-5. Ginekol Pol. 2004. PMID: 15751219 Polish.

4

Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.

Brojer E, Zupanska B, Guz K, Orziñska A, Kaliñska A. Brojer E, et al. Among authors: guz k. Transfusion. 2005 Sep;45(9):1473-80. doi: 10.1111/j.1537-2995.2005.00559.x. Transfusion. 2005. PMID: 16131380

5

[Fetal D gene in maternal plasma should be examined in all immunized Rh(-) pregnant women to avoid invasive procedures].

Zupańska B, Orzińska A, Nowaczek-Migas M, Guz K, Wielgoś M, Debski R, Gibała A, Rumas-Bec J, Brojer E. Zupańska B, et al. Among authors: guz k. Ginekol Pol. 2006 May;77(5):359-64. Ginekol Pol. 2006. PMID: 16958225 Polish.

6

Preliminary results of fetal Rhc examination in plasma of pregnant women with anti-c.

Orzińska A, Guz K, Brojer E, Zupańska B. Orzińska A, et al. Among authors: guz k. Prenat Diagn. 2008 Apr;28(4):335-7. doi: 10.1002/pd.1977. Prenat Diagn. 2008. PMID: 18382999

7

[Noninvasive prenatal diagnosis from maternal plasma in serological conflicts in Poland: current practice and future prospects].

Orzińska A, Guz K, Brojer E. Orzińska A, et al. Among authors: guz k. Ginekol Pol. 2009 Oct;80(10):768-71. Ginekol Pol. 2009. PMID: 19943542 Polish.

8

RHD variants in Polish blood donors routinely typed as D-.

Orzińska A, Guz K, Polin H, Pelc-Kłopotowska M, Bednarz J, Gieleżyńska A, Sliwa B, Kowalewska M, Pawłowska E, Włodarczyk B, Malaga Alicja Żmudzin M, Krzemienowska M, Srivastava K, Michalewska B, Gabriel C, Flegel WA, Brojer E. Orzińska A, et al. Among authors: guz k. Transfusion. 2013 Nov;53(11 Suppl 2):2945-53. doi: 10.1111/trf.12230. Epub 2013 May 1. Transfusion. 2013. PMID: 23634715 Free PMC article.

9

Analysis of leucocyte antibodies, cytokines, lysophospholipids and cell microparticles in blood components implicated in post-transfusion reactions with dyspnoea.

Maślanka K, Uhrynowska M, Łopacz P, Wróbel A, Smoleńska-Sym G, Guz K, Lachert E, Ostas A, Brojer E. Maślanka K, et al. Among authors: guz k. Vox Sang. 2015 Jan;108(1):27-36. doi: 10.1111/vox.12190. Epub 2014 Aug 18. Vox Sang. 2015. PMID: 25134637 Clinical Trial.

10

[PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].

Uhrynowska ME, Dębska M, Guz K, Orzińska A, Wróbel A, Maślanka K, Dębski R, Brojer E. Uhrynowska ME, et al. Among authors: guz k. Ginekol Pol. 2015 Jan;86(1):62-6. doi: 10.17772/gp/1901. Ginekol Pol. 2015. PMID: 25775877 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page